Insulet Corporation (PODD)
Insulet stock today
Insulet closed at $149.68 on October 30, 2026, down 1.85% on the day. Over the past year it returned -52.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $10.4 billion.
| Period | PODD | S&P 500 (SPY) |
|---|---|---|
| 1 month | +14.7% | -0.9% |
| 3 months | -9.7% | +2.1% |
| Year to date | -47.3% | +11.7% |
| 1 year | -52.0% | +12.4% |
| 3 years | +14.5% | +88.5% |
| 5 years | -51.7% | +76.0% |
Key statistics
- Market value
- $10.4B
- P/E (trailing)
- 28.1
- Forward P/E
- 21.0
- Price / sales
- 3.4
- 52-week range
- $130.47 to $346.36
- Next report
- Nov 4, 2026
About Insulet
Manufactures and sells insulin infusion pumps and related diabetes management devices.
Sector: Health Care · Industry: Health Care Equipment
More on Insulet
- Financials: revenue, earnings and segmentsRevenue +31% in the year to Dec 2025
- Valuation: P/E history and peersP/E 28.1, median 73.8 at its last 3 year ends
- Returns: what $1,000 became$1,000 ten years ago is $4,044 today
No forecast, no recommendation. This page describes Insulet Corporation from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.